CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 88 enrolled
Drug / intervention
Photodynamic therapy using polyhematoporphyrinprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02504957
NCT02504957N/ACompleted
CompareCT.gov

Photodynamic Therapy With Polyhematoporphyrin for Malignant Biliary Obstruction - a Retrospective Analysis.

Medical University of Vienna·interventional·Posted Jul 22, 2015·Updated Oct 26, 2015

In Brief

A clinical study evaluating Photodynamic therapy using polyhematoporphyrin for Klatskin's Tumor. Completed, enrolled 88 participants.

Detailed Summary

Photodynamic therapy (PDT) is a palliative treatment for malignant biliary obstruction. The aim of this study is to assess the feasibility and safety of this technique in the context of a nationwide retrospective analysis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKlatskin's Tumor
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 22, 2015
Enrollment StartJul 1, 2015
Primary CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 10.9 years ago

Interventions

Photodynamic therapy using polyhematoporphyrinprocedure